Solventum Corp. (SOLV) - Total Assets
Based on the latest financial reports, Solventum Corp. (SOLV) holds total assets worth $13.97 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Solventum Corp.'s book value for net asset value and shareholders' equity analysis.
Solventum Corp. - Total Assets Trend (2021–2024)
This chart illustrates how Solventum Corp.'s total assets have evolved over time, based on quarterly financial data.
Solventum Corp. - Asset Composition Analysis
Current Asset Composition (December 2024)
Solventum Corp.'s total assets of $13.97 Billion consist of 22.5% current assets and 77.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.3% |
| Accounts Receivable | $1.23 Billion | 8.5% |
| Inventory | $965.00 Million | 6.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.54 Billion | 17.6% |
| Goodwill | $6.38 Billion | 44.1% |
Asset Composition Trend (2021–2024)
This chart illustrates how Solventum Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Solventum Corp..
Key Asset Composition Facts
- Current vs. Non-Current Assets: Solventum Corp.'s current assets represent 22.5% of total assets in 2024, an increase from 15.6% in 2021.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2024, up from 0.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 61.0% of total assets, a decrease from 73.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 44.1% of total assets.
Solventum Corp. Competitors by Total Assets
Key competitors of Solventum Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
Solventum Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.50 | 1.15 | 1.70 |
| Quick Ratio | 1.14 | 0.83 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.47 Billion | $450.00 Million | $920.00 Million |
Solventum Corp. - Advanced Valuation Insights
This section examines the relationship between Solventum Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.72 |
| Latest Market Cap to Assets Ratio | 0.80 |
| Asset Growth Rate (YoY) | 3.7% |
| Total Assets | $14.46 Billion |
| Market Capitalization | $11.56 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Solventum Corp.'s assets below their book value (0.80x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Solventum Corp.'s assets grew by 3.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Solventum Corp. (2021–2024)
The table below shows the annual total assets of Solventum Corp. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $14.46 Billion | +3.69% |
| 2023-12-31 | $13.94 Billion | +2.57% |
| 2022-12-31 | $13.59 Billion | -3.42% |
| 2021-12-31 | $14.07 Billion | -- |
About Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more